644 related articles for article (PubMed ID: 34975867)
21. Immune characterization of metastatic colorectal cancer patients post reovirus administration.
Parakrama R; Fogel E; Chandy C; Augustine T; Coffey M; Tesfa L; Goel S; Maitra R
BMC Cancer; 2020 Jun; 20(1):569. PubMed ID: 32552875
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer.
Lee KS; Kwak Y; Ahn S; Shin E; Oh HK; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
Cancer Immunol Immunother; 2017 Jul; 66(7):927-939. PubMed ID: 28405764
[TBL] [Abstract][Full Text] [Related]
23. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
[TBL] [Abstract][Full Text] [Related]
24. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer.
Dou R; Nishihara R; Cao Y; Hamada T; Mima K; Masuda A; Masugi Y; Shi Y; Gu M; Li W; da Silva A; Nosho K; Zhang X; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Qian ZR; Ogino S
Cancer Immunol Res; 2016 Nov; 4(11):927-935. PubMed ID: 27737877
[TBL] [Abstract][Full Text] [Related]
27. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
28. The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
Marisa L; Svrcek M; Collura A; Becht E; Cervera P; Wanherdrick K; Buhard O; Goloudina A; Jonchère V; Selves J; Milano G; Guenot D; Cohen R; Colas C; Laurent-Puig P; Olschwang S; Lefèvre JH; Parc Y; Boige V; Lepage C; André T; Fléjou JF; Dérangère V; Ghiringhelli F; de Reynies A; Duval A
J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922790
[TBL] [Abstract][Full Text] [Related]
29. Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.
Xie S; Huang J; Qiao Q; Zang W; Hong S; Tan H; Dong C; Yang Z; Ni L
Cancer Immunol Immunother; 2018 Nov; 67(11):1685-1694. PubMed ID: 30128738
[TBL] [Abstract][Full Text] [Related]
30. The PD-1 expressing immune phenotype of T cell exhaustion is prominent in the 'immunoreactive' microenvironment of colorectal carcinoma.
Prall F; Hühns M
Histopathology; 2017 Sep; 71(3):366-374. PubMed ID: 28383777
[TBL] [Abstract][Full Text] [Related]
31. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Cantero-Cid R; Casas-Martin J; Hernández-Jiménez E; Cubillos-Zapata C; Varela-Serrano A; Avendaño-Ortiz J; Casarrubios M; Montalbán-Hernández K; Villacañas-Gil I; Guerra-Pastrián L; Peinado B; Marcano C; Aguirre LA; López-Collazo E
BMC Cancer; 2018 Oct; 18(1):945. PubMed ID: 30285662
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Importance of CD20
Edin S; Kaprio T; Hagström J; Larsson P; Mustonen H; Böckelman C; Strigård K; Gunnarsson U; Haglund C; Palmqvist R
Sci Rep; 2019 Dec; 9(1):19997. PubMed ID: 31882709
[TBL] [Abstract][Full Text] [Related]
34. The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment.
Neupane P; Mimura K; Nakajima S; Okayama H; Ito M; Thar Min AK; Saito K; Onozawa H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Kono K
Anticancer Res; 2021 Oct; 41(10):4895-4905. PubMed ID: 34593437
[TBL] [Abstract][Full Text] [Related]
35. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
36. Clonally expanded EOMES
Bonnal RJP; Rossetti G; Lugli E; De Simone M; Gruarin P; Brummelman J; Drufuca L; Passaro M; Bason R; Gervasoni F; Della Chiara G; D'Oria C; Martinovic M; Curti S; Ranzani V; Cordiglieri C; Alvisi G; Mazza EMC; Oliveto S; Silvestri Y; Carelli E; Mazzara S; Bosotti R; Sarnicola ML; Godano C; Bevilacqua V; Lorenzo M; Siena S; Bonoldi E; Sartore-Bianchi A; Amatu A; Veronesi G; Novellis P; Alloisio M; Giani A; Zucchini N; Opocher E; Ceretti AP; Mariani N; Biffo S; Prati D; Bardelli A; Geginat J; Lanzavecchia A; Abrignani S; Pagani M
Nat Immunol; 2021 Jun; 22(6):735-745. PubMed ID: 34017124
[TBL] [Abstract][Full Text] [Related]
37. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
Cui G; Yuan A; Li Z; Goll R; Florholmen J
Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
[TBL] [Abstract][Full Text] [Related]
38. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.
Löfroos AB; Kadivar M; Resic Lindehammer S; Marsal J
Eur J Med Res; 2017 Oct; 22(1):40. PubMed ID: 29020986
[TBL] [Abstract][Full Text] [Related]
40. Differences in circulating lymphocyte subpopulations among patients with inflammatory polyps, colorectal adenomas and colorectal cancer.
Zheng J; Jin H; Tu Y
Arab J Gastroenterol; 2024 May; 25(2):129-134. PubMed ID: 38413325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
